Targeted MRI/ultrasound beats standard biopsy to detect high-risk prostate cancer

Targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer, according to a large-scale study.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1Lfg1tD